drugset / Trial / NCT02079766
18F-AV-1451 and Florbetapir F 18 PET (Positron Emission Tomography) Imaging in Subjects at Risk for Chronic Traumatic Encephalopathy
Non-randomizedParallel-groupOpen-labelDiagnostic
Summary
This study will explore the use of flortaucipir as a biomarker for chronic traumatic encephalopathy (CTE) and examine the relationship between clinical presentation and tau deposition.
Timeline
- Start
- 2014-06
- Primary completion
- 2015-10
- Completion
- 2015-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Flortaucipir F18 | Diagnostic / imaging agent | 370 mbq | Intravenous |
| Subject | florbetapir F 18 | Diagnostic / imaging agent | 370 mbq | Intravenous |